● Recruiting

PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.

Condition: Liver Cancer · Sponsor: West China Hospital

PhasePhase 1

Planned participants9

Who can joinAll sexes, 18 Years to 70 Years

Healthy volunteersNo

About this study

Evaluating the Safety and Efficacy of PD-1 mRNA LNP Vaccine Therapy in Patients with Primary Hepatocellular Carcinoma Who Have Failed Advanced Standard Therapy

This description comes directly from the study's public registry record.

Talk to the study team

Xingchen Peng · 18980606753 · pxx2014@163.com

Always discuss trial participation with your own doctor first.

Locations (2)

West China Hospital, Sichuan University	Chengdu, Sichuan, China	Not Yet Recruiting
Sichuan University West China Hospital	Chengdu, Sichuan, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07053072